Status:
UNKNOWN
Microbial Colonization of Oral Probiotics
Lead Sponsor:
BLIS Technologies Limited
Conditions:
Microbial Colonization
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the colonization efficacy of probiotic lozenges and powders containing specific prebiotics in healthy adults
Detailed Description
This is a double-blind, randomized controlled colonization pilot study with no cross over to evaluate the colonization efficacy of lozenges and powders containing two different commercially available ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Male or Female 18y - 80y age
- In general good health 18 - 80 years of age.
- Practice good oral hygiene.
- Exclusion criteria:
- Have a history of autoimmune disease or are immunocompromised.
- Are on concurrent antibiotic therapy or regular antibiotic use within last 1 week
- History of allergy (e.g. dairy).
Exclusion
Key Trial Info
Start Date :
June 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05375383
Start Date
June 15 2022
End Date
September 15 2022
Last Update
May 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Blis Technologies Ltd
Dunedin, Otago, New Zealand, 9012